Kai Wirt@Aktien2022

2Anno

I would still keep Novavax and possibly wait that the vlt bring out new vaccines, which can increase sales. I am also in the red with them...🥴

Mostra originale (Tedesco)

Mi piace••Risposta

Leuchtturm@Leuchtturm

2Anno

@Aktien2022 what does the company's information say about the development of new vaccines, so long the company is not to be seen as "growth potential"

Mostra originale (Tedesco)

Mi piace••Risposta

Leuchtturm@Leuchtturm

2Anno

@Aktien2022 because research is one thing - clinical trials and market approvals are another 🤔.

Mostra originale (Tedesco)

Mi piace••Risposta